Research and Markets has announced the addition of the "Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2016" report to their offering.
'Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2016'; Congestive Heart Failure (Heart Failure) pipeline therapeutics constitutes close to 126 molecules. Out of which approximately 100 molecules are developed by Companies and remaining by the Universities
Congestive Heart Failure (Heart Failure) Heart failure is also known as congestive heart failure (CHF). CHF is a condition in which the heart is no longer able to pump out enough oxygen-rich blood. Symptoms include cough, fatigue, weakness, faintness, loss of appetite, swollen (enlarged) liver or abdomen, swollen feet and ankles and weight gain. The predisposing factors include high blood pressure, diabetes, sleep apnea, alcohol use and irregular heartbeats. Treatment includes surgery, vasodilator, beta blockers and diuretics.
The report 'Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2016' outlays comprehensive information on the therapeutics under development for Congestive Heart Failure (Heart Failure), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type; that are being developed by Companies / Universities.
It also reviews of key players involved in therapeutic development for Congestive Heart Failure (Heart Failure) and features dormant and discontinued projects. Currently, The molecules developed by Companies in Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 1, 15, 30, 11, 2, 35 and 6 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 18 and 8 molecules, respectively.
Key Topics Covered:
For more information about this report visit http://www.researchandmarkets.com/research/ph98pm/congestive_heart
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161013005937/en/Business Wire
Last updated on: 13/10/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.